Type 3
Showing 1 - 25 of >10,000
Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)
Not yet recruiting
- Gaucher Disease, Type 3
- Gene therapy
- Enzyme Replacement Agent
- (no location specified)
Apr 14, 2023
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER
Not yet recruiting
- Gaucher Disease, Type 3
- No intervention
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 16, 2022
Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
-
Panama City, Panama
- +3 more
Dec 14, 2022
Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)
Not yet recruiting
- Group 3 Pulmonary Hypertension
- recombinant human brain natriuretic peptide
- Placebo
- (no location specified)
Jan 30, 2023
Hamstring Injury, Muscle Rupture, Hamstring Sprain Trial (NMES+, Rehab)
Not yet recruiting
- Hamstring Injury
- +2 more
- NMES+
- Rehab
- (no location specified)
Mar 29, 2023
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin
Active, not recruiting
- Poliomyelitis
- Novel Oral Polio Vaccine Type 1 (nOPV1)
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 24, 2022
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease Trial in Nijmegen (VO659)
Recruiting
- Spinocerebellar Ataxia Type 1
- +2 more
-
Nijmegen, NetherlandsRadbout University Medical Centre
Apr 7, 2023
Spinocerebellar Ataxia Type 3 Trial in Fuzhou (Active repetitive transcranial magnetic stimulation, Sham repetitive transcranial
Completed
- Spinocerebellar Ataxia Type 3
- Active repetitive transcranial magnetic stimulation
- Sham repetitive transcranial magnetic stimulation
-
Fuzhou, Fujian, ChinaDepartment of Neurology ,First Affiliated Hospital Fujian Medica
Aug 14, 2022
Characterization and Type 3c Diabetes Mellitus Secondary to
Recruiting
- Pancreatic Cancer
- +2 more
- Data Management and Monitoring
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 25, 2022
Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III Trial (Bone marrow-derived mesenchymal stromal cells (MSCs))
Not yet recruiting
- Osteogenesis Imperfecta
- Osteogenesis Imperfecta Type III
- Bone marrow-derived mesenchymal stromal cells (MSCs)
- (no location specified)
Nov 28, 2022
Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)
Active, not recruiting
- Gaucher Disease Type 1
- Gaucher Disease Type 3
- venglustat (GZ402671)
- imiglucerase
-
New Haven, Connecticut
- +6 more
Aug 9, 2022
Nicotine Use Disorder Trial (E-liquid coolant (no WS-3) (1), E-liquid coolant (Low WS-3) (1), E-liquid coolant (High WS-3) (1))
Not yet recruiting
- Nicotine Use Disorder
- E-liquid coolant (no WS-3) (1)
- +8 more
- (no location specified)
Jul 7, 2023
Diabetes, Type 2, Diabetes, Type 1, Gastroparesis With Diabetes Trial in Cleveland (FreeStyle Libre 3 continuous glucose
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- FreeStyle Libre 3 continuous glucose monitoring sensor
-
Cleveland, OhioCleveland Clinic Foundation
Sep 6, 2023
Von Willebrand Disease Trial (Alphanate SD/HT)
Active, not recruiting
- Von Willebrand Disease
- Alphanate SD/HT
- (no location specified)
May 5, 2022
E-Cig Use Trial (E-liquid coolant (WS-3, 0.1%), E-liquid coolant (WS-3, 0.25%), E-liquid coolant (WS-3, 0.5%))
Not yet recruiting
- E-Cig Use
- E-liquid coolant (WS-3, 0.1%)
- +9 more
- (no location specified)
Jun 28, 2023
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3 Trial in New York (High-Intensity
Recruiting
- Spinocerebellar Ataxia Type 1
- +4 more
- High-Intensity Aerobic Exercise Prior to Balance Training
- Low-Intensity Exercise Prior to Balance Training
-
New York, New YorkTeachers College, Columbia University
Apr 21, 2023
Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty
Completed
- Type 2 Diabetes Mellitus
- +2 more
- omega-3 polyunsaturated fatty acids
- corn oil
-
Lianshui, Jiangsu, ChinaLian Shui People's Hospital
Oct 2, 2023
Pancretic Cancer, Diabete Mellitus Trial (Metformin or insulin treatment)
Not yet recruiting
- Pancretic Cancer
- Diabete Mellitus
- Metformin or insulin treatment
- (no location specified)
Mar 23, 2022
Sensory Profiles, Nociplastic Pain, Low Back Pain Trial
Recruiting
- Sensory Profiles, Nociplastic Pain, Low Back Pain
-
Zwolle, Overijssel, NetherlandsFysiomobilae
Oct 12, 2022
Diabetes, Type 1 Trial in Cairo (oral omega-3 fatty acids supplementation, Placebo)
Completed
- Diabetes Mellitus, Type 1
- oral omega-3 fatty acids supplementation
- Placebo
-
Cairo, EgyptNancy Elbarbary
Aug 4, 2023
Gaucher's Disease Type III Trial in Fairfax, Beijing, Guangzhou (Venglustat, imiglucerase)
Recruiting
- Gaucher's Disease Type III
-
New Haven, Connecticut
- +13 more
Jan 13, 2023
Transcranial Alternating Current Stimulation(tACS)on Cerebellar
Recruiting
- Spinocerebellar Ataxia Type 3
- Multiple System Atrophy-cerebellar Type
- Transcranial Alternating Current Stimulation
-
Fuzhou, Fujian, ChinaDepartment of Neurology, The First Affiliated Hospital Fujian Me
Oct 6, 2022
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023